Present study | Papagiannaki et al18 | Caroff et al11 | WEBCAST16 | |
---|---|---|---|---|
No of aneurysms | 114 | 85 | 98 | 51 |
Ruptured aneurysms | 47 (41.2%) | 4 (4.7%) | 33 (33.7%) | 3 (5.9%) |
No of patients | 108 | 83 | 90 | 51 |
Anatomic result | ||||
Adequate occlusion | 68/90 (75.6%) | 60/65 (92.3%) | 45/69 (65.2%) | 35/41 (85.4%) |
Aneurysm remnant | 22/90 (24.4%) | 5/65 (7.7%) | 24/69 (34.8%)* | 6/41 (14.6%) |
Retreatment | 15/90 (16.7%) | 0/65 (0.0%) | n/a | 0/41 (0.0%) |
Permanent morbidity | 5/94 (5.3%)† | 1/77 (1.3%) | 4/90 (4.4%)‡ | 1/51 (2.0%) |
Mortality | 8/94 (8.5%)§ | 0/77 (0.0%) | 1/90 (1.1%)¶ | 0/51 (0.0%)** |
*Numbers are concluded indirectly from the published data of the author.
†n=94, number of patients available for follow-up plus deceased patients.
‡Morbidity defined as modified Rankin Scale score >1.
§Seven of eight patients died following subarachnoid hemorrhage; one patient died in the interim due to stomach cancer.
¶Described as ‘treatment-related mortality’; total mortality rate not available.
**Retreatment foreseen in three of six patients with aneurysm remnant.